| Identification | Back Directory | [Name]
2’-O-Acetyl-N4-benzoyl-5’-O-(4,4’-dimethoxytrityl) arabinocytidine 3’-O-phosphoramidite | [CAS]
675573-97-4 | [Synonyms]
DMTr-2'-ara-OAc-C(Bz)-3'-CE-Phosphoramidite
2’-O-Acetyl-N4-benzoyl-5’-O-DMT arabinocytidine 3’-O-phosphoramidite
2'-O-Ac-N4-Bz-5'-O-(4,4'-dimethoxytrityl) arabinocytidine 3'-O-phosphoramidite
2’-O-Acetyl-N4-benzoyl-5’-O-(4,4’-dimethoxytrityl)arabinocytidine3’-O-phosphoramidite
2’-O-Acetyl-N4-benzoyl-5’-O-(4,4’-dimethoxytrityl) arabinocytidine 3’-O-phosphoramidite
Benzamide, N-[1-[2-O-acetyl-5-O-[bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-β-D-arabinofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]- | [Molecular Formula]
C48H54N5O10P | [MOL File]
675573-97-4.mol | [Molecular Weight]
891.96 |
| Hazard Information | Back Directory | [Uses]
2’-O-Acetyl-N4-benzoyl-5’-O-DMT arabinocytidine 3’-O-phosphoramidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|